-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Pacira BioSciences, Raises Price Target to $33

Benzinga·08/05/2026 11:47:27
Listen to the news
Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and raises the price target from $32 to $33.